Array
(
[id] => 15436131
[patent_doc_number] => 20200032249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => LABELING, ISOLATION, & ANALYSIS OF RNA FROM RARE CELL POPULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/493716
[patent_app_country] => US
[patent_app_date] => 2018-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493716
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493716 | LABELING, ISOLATION, & ANALYSIS OF RNA FROM RARE CELL POPULATIONS | Mar 12, 2018 | Abandoned |
Array
(
[id] => 14963563
[patent_doc_number] => 20190309260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => ARTIFICIAL ANTIGEN-PRESENTING CELL PREPARED FROM HLA-NULL CELL LINE BY USING MULTIPLEX CRISPR-CAS9 SYSTEM AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/465933
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465933
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465933 | Artificial antigen-presenting cell prepared from HLA-null cell line by using multiplex CRISPR-CAS9 system and use thereof | Nov 30, 2017 | Issued |
Array
(
[id] => 15768829
[patent_doc_number] => 20200115432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => AN ENGINEERED TWO-PART CELLULAR DEVICE FOR DISCOVERY AND CHARACTERISATION OF T-CELL RECEPTOR INTERACTION WITH COGNATE ANTIGEN
[patent_app_type] => utility
[patent_app_number] => 16/347716
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347716
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347716 | AN ENGINEERED TWO-PART CELLULAR DEVICE FOR DISCOVERY AND CHARACTERISATION OF T-CELL RECEPTOR INTERACTION WITH COGNATE ANTIGEN | Nov 6, 2017 | Abandoned |
Array
(
[id] => 18948345
[patent_doc_number] => 11891627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Mechanical apparatus and method for isolating stromal vascular fraction
[patent_app_type] => utility
[patent_app_number] => 15/579802
[patent_app_country] => US
[patent_app_date] => 2016-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 9178
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579802
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579802 | Mechanical apparatus and method for isolating stromal vascular fraction | Jun 8, 2016 | Issued |